Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

被引:122
作者
Price, P
Morahan, G
Huang, DX
Stone, E
Cheong, KYM
Castley, A
Rodgers, M
McIntyre, MQ
Abraham, LJ
French, MA
机构
[1] Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA 6001, Australia
[2] Univ Western Australia, Dept Pathol, Nedlands, WA 6009, Australia
[3] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia
[4] Univ Western Australia, Sch Biomed & Chem Sci, Nedlands, WA 6009, Australia
关键词
anti-retroviral therapy; cytokine genes; cytomegalovirus; HIV; polymorphism;
D O I
10.1097/00002030-200210180-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To further elucidate the immunopathogenesis of immune restoration diseases (IRD) in HIV patients responding to antiretroviral therapy and determine whether IRD associated with different opportunistic pathogens involve distinct immunopathological mechanisms. Design: DNA samples from patients with a range of IRD were typed for polymorphic loci in genes encoding immune-mediators. Methods: PCR-restriction fragment length polymorphism assays were used to type loci in the IL1A, IL1B, IL6, TNFA and IL12B genes. Alleles of a microsatellite in the CD30 promoter were determined by capillary electrophoresis. Results: Only 8% of patients with IRD associated with a herpesvirus infection carried IL12B-3'UTR*2, compared with 42-54% of patients with other or no IRD. Patients with IRD arising from mycobacterial infection rarely carried IL6-174*C (36% versus 61-71%) and never carried TNFA-308*2 (0% versus 23-52%). TNFA-308*2 was carried by 52% of patients who experienced IRD associated with a herpesvirus infection, as several patients with exacerbations of cytomegalovirus retinitis carried this as part of a HLA-A2,B44 haplotype. Polymorphisms in IL1A, IL1B and CD30 showed no distinct patterns. Conclusions: Distinct cytokine-mediated mechanisms contribute to IRD initiated by herpesvirus and mycobacterial infections. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:2043 / 2047
页数:5
相关论文
共 23 条
[1]   Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene [J].
Croager, EJ ;
Gout, AM ;
Abraham, LJ .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05) :1723-1731
[2]   Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy [J].
DeSimone, JA ;
Pomerantz, RJ ;
Babinchak, TJ .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) :447-454
[3]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[4]   Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients [J].
Foudraine, NA ;
Hovenkamp, E ;
Notermans, DW ;
Meenhorst, PL ;
Klein, MR ;
Lange, JMA ;
Miedema, F ;
Reiss, P .
AIDS, 1999, 13 (02) :177-184
[5]  
French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x
[6]   ZIDOVUDINE-INDUCED RESTORATION OF CELL-MEDIATED-IMMUNITY TO MYCOBACTERIA IN IMMUNODEFICIENT HIV-INFECTED PATIENTS [J].
FRENCH, MAH ;
MALLAL, SA ;
DAWKINS, RL .
AIDS, 1992, 6 (11) :1293-1297
[7]  
French Martyn, 2002, J HIV Ther, V7, P46
[8]   Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts [J].
Hassell, M ;
French, MA .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (12) :889-891
[9]   Immune recovery vitritis and uveitis in AIDS - Clinical predictors, sequelae, and treatment outcomes [J].
Karavellas, MP ;
Azen, SP ;
MacDonald, JC ;
Shufelt, CL ;
Lowder, CY ;
Plummer, DJ ;
Glasgow, B ;
Torriani, FJ ;
Freeman, WR .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2001, 21 (01) :1-9
[10]   Effects of stimulus and cell type on the expression of the - 308 tumour necrosis factor promoter polymorphism [J].
Kroeger, KM ;
Steer, JH ;
Joyce, DA ;
Abraham, LJ .
CYTOKINE, 2000, 12 (02) :110-119